These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 18974847
1. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells. Kojic LD, Wiseman SM, Ghaidi F, Joshi B, Nedev H, Saragovi HU, Nabi IR. PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847 [Abstract] [Full Text] [Related]
2. Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells. Kojic LD, Joshi B, Lajoie P, Le PU, Cox ME, Turbin DA, Wiseman SM, Nabi IR. J Biol Chem; 2007 Oct 05; 282(40):29305-13. PubMed ID: 17690101 [Abstract] [Full Text] [Related]
4. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase. Fairbank M, St-Pierre P, Nabi IR. Mol Biosyst; 2009 Aug 05; 5(8):793-801. PubMed ID: 19603112 [Abstract] [Full Text] [Related]
5. Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release. Fu M, Li L, Albrecht T, Johnson JD, Kojic LD, Nabi IR. Cell Death Differ; 2011 Jun 05; 18(6):1057-70. PubMed ID: 21252914 [Abstract] [Full Text] [Related]
6. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14. Yanagawa T, Funasaka T, Tsutsumi S, Hu H, Watanabe H, Raz A. Cancer Res; 2007 Sep 15; 67(18):8682-9. PubMed ID: 17875708 [Abstract] [Full Text] [Related]
11. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Tsutsumi S, Hogan V, Nabi IR, Raz A. Cancer Res; 2003 Jan 01; 63(1):242-9. PubMed ID: 12517804 [Abstract] [Full Text] [Related]
12. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model. Shih WL, Yu FL, Chang CD, Liao MH, Wu HY, Lin PY. Mol Carcinog; 2013 Oct 01; 52(10):800-12. PubMed ID: 22549898 [Abstract] [Full Text] [Related]
13. Suppression of melanoma cell motility factor receptor expression by retinoic acid. Lotan R, Amos B, Watanabe H, Raz A. Cancer Res; 1992 Sep 15; 52(18):4878-84. PubMed ID: 1325286 [Abstract] [Full Text] [Related]
14. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Funasaka T, Hu H, Yanagawa T, Hogan V, Raz A. Cancer Res; 2007 May 01; 67(9):4236-43. PubMed ID: 17483335 [Abstract] [Full Text] [Related]
15. [The role of autocrine motility factor receptor in metastasis]. Watanabe H, Chigira M, Raz A. Gan To Kagaku Ryoho; 1993 Feb 01; 20(3):405-9. PubMed ID: 8382466 [Abstract] [Full Text] [Related]
18. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems. Tímár J, Rásó E, Döme B, Ladányi A, Bánfalvi T, Gilde K, Raz A. Clin Exp Metastasis; 2002 Feb 01; 19(3):225-32. PubMed ID: 12067203 [Abstract] [Full Text] [Related]
20. Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia KG1α cells. You ZM, Zhao L, Xia J, Wei Q, Liu YM, Liu XY, Chen DL, Li J. Asian Pac J Cancer Prev; 2014 Feb 01; 15(3):1099-104. PubMed ID: 24606425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]